Sweden· SE-20041213000146
Engerix-B 20 mikrogram/1 ml Injektionsvätska, suspension, förfylld spruta
A medicinal product containing hepatitis b surface antigen (rdna), algeldrate, registered in Sweden by GlaxoSmithKline AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Hepatitis B Surface Antigen (Rdna), Algeldrate
- Manufacturer
- GlaxoSmithKline AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20041213000146
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/caa7b656-3986-4963-ae78-6366ef48c366 GET /v1/drugs/caa7b656-3986-4963-ae78-6366ef48c366?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"SmPC"
],
"se_npl_id": "20041213000146",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20041213000146",
"product_doc_link": "https://docetp.mpa.se/LMF/Engerix-B%2020%20microgram%20per%201%20ml%20suspension%20for%20injection%2C%20pre-filled%20syringe%20SmPC_09001bee807a16ed.pdf"
}See everything about hepatitis b surface antigen (rdna), algeldrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.